Bioanalysis Laboratory in Pleasanton, California (San Francisco Bay Area)
Crystal Bio Solutions, part of Crystal Group, operates a GLP- and GCLP-compliant bioanalysis and biomarker laboratory in Pleasanton, California, in the East Bay of the San Francisco Bay Area. Our scientists develop, validate and run PK, immunogenicity (ADA and NAb), receptor occupancy and biomarker assays for biologics, ADCs and other modalities, and support clinical studies with central lab kitting and sample management.
Visiting or Shipping Samples to Pleasanton
Address: 7133 Koll Center Parkway, Suite 200, Pleasanton, CA 94566Phone: +1 925-558-5040 (Mon–Fri, 9 a.m.–5 p.m. Pacific)
Email: cbs_bd@crystalpharmatech.com
Please contact us before shipping samples so we can confirm the study, send shipping instructions and, for clinical studies, provide collection kits. Sponsor visits and audits can be arranged.
Working With Our Pleasanton Laboratory
Pleasanton is in the Tri-Valley area of the East Bay, within driving distance of biotech centers such as South San Francisco, Emeryville, Fremont and San Jose. Bay Area teams can meet our scientists in person for study kickoff, method reviews and audits, and work in the same time zone.
- Quality system: GLP- and GCLP-compliant operations with an independent QA unit, and computerized systems that follow 21 CFR Part 11 with audit trails. See Quality and Compliance.
- Staged method work: development, qualification for early or non-GLP studies, and validation following ICH M10 (PK) or FDA immunogenicity guidance (ADA and NAb) for regulated studies.
- Platforms: ELISA, MSD, Gyrolab, Luminex, SP-X, flow cytometry, qPCR and LC-MS/MS (SCIEX 7500).
- HRMS support: for complex analytes, such as ADC payloads and catabolites or modified proteins, our Natick, Massachusetts team provides high-resolution mass spectrometry for structural information during method development.
Related Services
Frequently Asked Questions
Where is the Crystal Bio Solutions bioanalysis laboratory?
At 7133 Koll Center Parkway, Suite 200, Pleasanton, California 94566, in the East Bay of the San Francisco Bay Area. The central lab and sample kitting operations are at the same site.
Is the Pleasanton laboratory GLP- and GCLP-compliant?
Yes. The Pleasanton laboratory operates in compliance with GLP and GCLP, with an independent QA unit and computerized systems that follow 21 CFR Part 11. Methods for regulated studies are validated before sample analysis.
Which assays are run in Pleasanton?
PK assays (including total antibody, conjugated antibody or payload, and free payload for ADCs), ADA and NAb immunogenicity assays, receptor occupancy by flow cytometry, and biomarker assays by ligand-binding, flow cytometry, qPCR and LC-MS/MS.
Do you support nonclinical and clinical studies?
Yes. The laboratory supports discovery and nonclinical studies, including GLP toxicology studies, and clinical studies with sample kits, sample management and validated assays.
Can sponsors visit or audit the laboratory?
Yes. Sponsor visits and audits can be arranged, and quality agreements are available. Contact us to schedule.
How does the Pleasanton lab work with the Natick lab?
Our Natick, Massachusetts laboratory provides high-resolution mass spectrometry to support LC-MS method development in Pleasanton for complex analytes. Regulated sample analysis is performed in Pleasanton.
How do I start a project?
Email cbs_bd@crystalpharmatech.com, call +1 925-558-5040 or use our contact form. A scientist replies within one business day.
Related case studies
- Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD: Changing the minimum required dilution improved NAb assay sensitivity and drug tolerance.
- Representative Pooled Matrix Selection Is Critical in ADA Assays: How the choice of pooled negative-control matrix shifts the ADA screening cut point.
- A Generic LC-MS/MS Solution for ADC PK Bioanalysis: A generic LC-MS/MS workflow for total antibody and conjugated payload in ADC PK studies.
- An Immunogenicity Analysis Strategy to Reduce Interference from Soluble Target Proteins: Reducing soluble-target interference in ADA assays.
- Receptor Occupancy of an Antibody Drug Measured by Flow Cytometry: Flow cytometry measurement of receptor occupancy for an antibody drug.
- An LC-MS/MS Method for Oligonucleotide PK Bioanalysis: An LC-MS/MS method for oligonucleotide quantitation in PK studies.
- Immunophenotyping to Identify Peripheral Lymphocyte Subsets: A flow cytometry panel to identify peripheral lymphocyte subsets.
- Sample Pretreatment Approaches to Improve Drug Tolerance in ADA Assays: Sample pretreatment options that improve ADA assay drug tolerance.
Discuss your assay with Dr. Meina Liang, our Chief Scientific Officer
Bring a real PK, immunogenicity, receptor occupancy or biomarker problem to the leader who supervises our bioanalysis projects. One hour at no cost, with a CDA in place first. Our business development team replies within one business day.
Ready to Start a Project?
Tell us about your study. Our business development team replies within one business day.
Request a Proposal